Table of Contents

List of contributors; Foreword; Part I. Introduction to Assisted Reproductive Technology Surveillance: 1. Infertility and assisted reproductive technology Sheree L. Boulet, Anjani Chandra, Aaron Rosen and Alan DeCherney; 2. Importance and history of assisted reproductive technology surveillance Jacques de Mouzon, Paul Lancaster and Anders Nyboe Andersen; Part II. General Principles of Assisted Reproductive Technology Surveillance: 3. Assisted reproductive technology surveillance: who, what, when, and how? Sara Crawford, Dmitry M. Kissin and Georgina Chambers; 4. Future directions for assisted reproductive technology surveillance and monitoring novel technology Christian De Geyter and Eli Y. Adashi; Part III. Using Assisted Reproductive Technology Surveillance Data: 5. Reporting assisted reproductive technology success rates Georgina Chambers, Kevin Doody and Sara Crawford; 6. Using assisted reproductive technology surveillance data in clinical research Valerie L. Baker, Sheree L. Boulet and Anja Bisgaard Pinborg; 7. Monitoring assisted reproductive technology safety and biovigilance Luca Gianaroli, Anna Pia Ferraretti and Borut Kovacic; 8. Quality assurance of assisted reproductive technology practice: using data to improve clinical care Kevin Doody, Carlos Calhaz-Jorge and Jesper Smeenk; 9. Monitoring long-term outcomes of assisted reproductive technology: linking surveillance data with other datasets Barbara Luke, Sheree L. Boulet and Anna-Karina Aaris Henningsen; 10. Use of assisted reproductive technology surveillance by infertility patients Sandra K. Dill, Edgar Mocanu and Petra Thorn; Part IV. Global Variations in Assisted Reproductive Technology Surveillance: 11. Global assisted reproductive technology surveillance: data from the international committee monitoring ART (ICMART) G. David Adamson; 12. Global variations in assisted reproductive technology policy: data from the international federation of fertility societies (IFFS) Steven J. Ory and Kathleen Miller; 13. ART surveillance in Africa Silke Dyer, Paversan Archary and G. David Adamson; 14. ART surveillance in Asia Osamu Ishihara, Manish Banker and Bai Fu; 15. ART surveillance in Australia and New Zealand Georgina Chambers, Paul Lancaster and Peter Illingworth; 16. ART surveillance in Europe Christian de Geyter, Markus S. Kupka and Carlos Calhaz-Jorge; 17. ART surveillance in the Middle East Johnny Awwad, Dalia Khalife and Ragaa Mansour; 18. ART surveillance in North America James Patrick Toner, Andrea Lanes and Dmitry M. Kissin; 19. ART surveillance in Latin America Fernando Zegers-Hochschild, Javier A. Crosby and Juan Enrique Schwarze; Part V. Surveillance of Non-ART Fertility Treatments: 20. The role of non-IVF fertility treatments in the management of infertility Christine Wyns, Diane de Neubourg and Eli Y. Adashi; 21. Non-ART surveillance Markus S. Kupka and Anja Bisgaard Pinborg; Appendix A. Assisted reproductive technology surveillance system variables and definitions; Appendix B. International glossary on infertility and fertility care; Appendix C. ICMART data collection form; Index.

Promotional Information

Offers a comprehensive guide to assisted reproductive technology surveillance, describing its history, global variations, and best practices.

About the Author

Dmitry Kissin is a Epidemiologist and Health Scientist in the area of reproductive health. He received a Doctor of Medicine degree in Obstetrics and Gynecology from St Petersburg State Medical University, Russia and a Master of Public Health degree in Epidemiology from State University of New York. He is leading the ART Surveillance and Research Team in Maternal and Infant Health Branch, Division of Reproductive Health, US Centers for Disease Control and Prevention. His team maintains the National ART Surveillance System and monitors effectiveness and safety of ART in the United States and conducts wide-ranging epidemiological and clinical research on many aspects of infertility and ART. Dr Kissin has published over 100 manuscripts in peer-reviewed journals and several book chapters. G. David Adamson is a reproductive endocrinologist and surgeon, Clinical Professor ACF at Stanford University, and Associate Clinical Professor at University of California, San Francisco. He is Past President of the American Society for Reproductive Medicine (ASRM), the Society for Assisted Reproductive Technology (SART), AAGL and Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) Reproductive Medicine Committee and several other major gynecological societies. He is Chair of ICMART and President of the World Endometriosis Research Foundation. He has over 300 scientific/medical publications and lectured extensively on ART, endometriosis and infertility. Dr Adamson helped lead development of the FIGO Fertility Toolbox, the Endometriosis Phenome and Biobanking Harmonization Project (EPHect), and he created the Endometriosis Fertility Index. He has also received many awards for contributions to reproductive medicine. Georgina Chambers is a University of New South Wales (UNSW) Scientia Fellow and Director of National Perinatal Epidemiology and Statistics Unit (NPESU), UNSW. She is the data custodian of the Australian and New Zealand Assisted Reproductive Technology Database (ANZARD) and a board member of the International Committee for Monitoring Assisted Reproductive Technologies (ICMART). Along with fifteen years' experience in both public and private healthcare sectors in Australia, she has a Ph.D. in health economics of assisted reproductive technologies (ART), and is considered an international expert in the health economics and epidemiology of ARTs. Christian De Geyter is a gynecological endocrinologist, as part of the division of Gynecological Endocrinology and Reproductive Medicine, at University Hospital Basel. He is the Chairman of the European IVF Monitoring Consortium, and also forms part of the research group Gynecological Endocrinology, in Switzerland.